Literature DB >> 33067685

Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter.

Mehmet Buğra Bozan1, Fatih Mehmet Yazar2, İlhami Taner Kale2, Mehmet Fatih Yüzbaşıoğlu2, Ömer Faruk Boran3, Ayşe Azak Bozan4.   

Abstract

BACKGROUND: It was aimed to evaluate the relationship between delta neutrophil index (DNI) and neutrophil-to-lymphocyte ratio (NLR) in the preoperative differentiation of nodular goiter and thyroid malignancy.
METHODS: Patients over the age of 18 who underwent thyroid surgery between November 2014 and November 2019 were evaluated in this retrospective cohort study. Patients were divided into two groups according to their pathology results: malignant (Group M) and benign (Group B) thyroid disorders. White blood cell (WBC) count, neutrophil count, lymphocyte count, IG count and DNI were measured using an automated hematological analyzer from blood samples obtained at the preoperative period and postoperative 6th month of the follow-up. Neutrophil-to-lymphocyte ratio (NLR) values were manually calculated. Numerical data are expressed as means ± standard deviations (minimum-maximum values) or medians (minimum-maximum values) according to the normal distribution. Categorical values are expressed as percentages (%).
RESULTS: A total of 243 patients (190 patients in Group B and 53 patients in Group M) who met the inclusion criteria were evaluated. The male/female ratio was 49/194. A statistically significant difference between Group M and Group B in terms of preoperative NLR, DNI and IG count was observed (p = 0.001, < 0.001 and < 0.001, respectively). No statistically significant difference was observed between the groups in terms of the control values performed in the postoperative period in terms of the NLR, DNI and IG count (p = 0.711, 0.333 and 0.714, respectively). A significant decrease was observed in the preoperative and postoperative DNIs, IG counts and NLRs in Group M (p = 0.009, < 0.001 and < 0.001, respectively). For the diagnosis of malignant thyroid diseases, the cut-off value of DNIs was ≥0.35%, and DNI sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 79.2%, 78.9%, 79.2% and 77.9%, respectively (area under the curve [AUC]: 0.847; confidence interval [CI]: 0.784-0.911). The cut-off value of the IG count was ≥25/mm3, and its sensitivity, specificity, PPV and NPV were 83%, 72.1%, 83%, and 72.1%, respectively (AUC: 0.847; CI: 0.784-0.911).
CONCLUSION: DNI and IG counts are cheap and easily accessible tests that can be automatically calculated from automated systems without additional cost in differentiation of thyroid malignancies from benign disorders in the preoperative period.

Entities:  

Mesh:

Year:  2020        PMID: 33067685     DOI: 10.1007/s00268-020-05822-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

Review 1.  Ultrasonographic thyroid findings suspicious for malignancy.

Authors:  Nami Azar; Craig Lance; Dean Nakamoto; Claire Michael; Jay Wasman
Journal:  Diagn Cytopathol       Date:  2013-12       Impact factor: 1.582

2.  Thyroid ultrasonographic charasteristics and Bethesda results after FNAB.

Authors:  Eleni Triantafillou; Georgios Papadakis; Fotini Kanouta; Styliani Kalaitzidou; Aspasia Drosou; Angeliki Sapera; Dimitra Tampouratzi; Michalis Kotis; Taxiarchis Kyrimis; Anna Dracopoulou; Eirini Veniou; Chrysa Karavasili; Victoria Kaltzidou; Styliani Plyta; Athanasia Tertipi
Journal:  J BUON       Date:  2018-12       Impact factor: 2.533

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 4.  Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

Authors:  Campbell S D Roxburgh; Donald C McMillan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

5.  Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer.

Authors:  De-shen Wang; Chao Ren; Miao-zhen Qiu; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  Tumour Biol       Date:  2011-12-24

6.  The 2017 Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2017-11       Impact factor: 6.568

7.  Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis.

Authors:  Gulali Aktas; Mustafa Sit; Oguz Dikbas; Hayri Erkol; Rabia Altinordu; Edip Erkus; Haluk Savli
Journal:  Rev Assoc Med Bras (1992)       Date:  2017-12       Impact factor: 1.209

Review 8.  The Diagnosis and Management of Thyroid Nodules: A Review.

Authors:  Cosimo Durante; Giorgio Grani; Livia Lamartina; Sebastiano Filetti; Susan J Mandel; David S Cooper
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

9.  An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer.

Authors:  Fang Lee; Po-Sheng Yang; Ming-Nan Chien; Jie-Jen Lee; Ching-Hsiang Leung; Shih-Ping Cheng
Journal:  Int J Med Sci       Date:  2018-11-23       Impact factor: 3.738

10.  Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer.

Authors:  Weiheng Wen; Peili Wu; Jitong Li; He Wang; Jia Sun; Hong Chen
Journal:  J Transl Med       Date:  2018-09-21       Impact factor: 5.531

View more
  1 in total

1.  Can the delta neutrophil ındex be used as a preliminary biomarker ın the evaluation of periodontal disease: a pilot study.

Authors:  Eda Çetin Özdemir; Emrah Bilen; Fatih M Yazar
Journal:  J Appl Oral Sci       Date:  2022-03-21       Impact factor: 2.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.